• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza season 2012-2013 in Europe: moderate intensity, mixed (sub)types

tetano

Editor, Senior Moderator
Epidemiol Infect. 2014 May 9:1-4. [Epub ahead of print]
Influenza season 2012-2013 in Europe: moderate intensity, mixed (sub)types.
Snacken R1, Broberg E1, Beaut? J1, Lozano JE2, Zucs P1, Amato-Gauci AJ1.
Author information
Abstract

SUMMARY This paper summarizes influenza activity in the European Union/European Economic Area (EU/EEA) in 2012-2013. The influenza season 2012-2013 in Europe lasted from early December to late April. Overall the severity of the season could be described as moderate, based on the ILI/ARI consultation rates and the percentage of sentinel specimens positive for influenza compared to previous seasons. Both influenza A and B viruses circulating accounted for 47% and 53% of positive sentinel specimens, respectively, with both A(H1) and A(H3) varying for dominance. Compared to outpatients, the proportion of laboratory-confirmed influenza hospitalized cases infected by A(H1N1)pdm09 was significantly higher in middle-aged patients (33% vs. 17%, χ 2 = 66?6, P < 0?01). Despite a relatively good match between vaccine and circulating strains, vaccine effectiveness was estimated to be moderate.

PMID:
24814635
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24814635
 
Back
Top Bottom